Fin Trust Capital Advisors, LLC Abiomed Inc Transaction History

Fin Trust Capital Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$285.92 - $355.13 $14,296 - $17,756	-50 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$255.22 - $317.0 $8,677 - $10,778	34 Added 212.5%	50 $14,000
Q2 2020 Sep 11, 2020	BUY	$141.4 - $257.09 $2,262 - $4,113	16 New	16 $4,000
Q2 2020 Aug 14, 2020	SELL	$141.4 - $257.09 $2,262 - $4,113	-16 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$130.51 - $196.01 $1,435 - $2,156	11 Added 220.0%	16 $2,000
Q4 2019 Jan 23, 2020	SELL	$159.31 - $223.54 $637 - $894	-4 Reduced 44.44%	5 $1,000
Q3 2019 Oct 29, 2019	BUY	$175.89 - $279.23 $351 - $558	2 Added 28.57%	9 $2,000
Q2 2019 Aug 01, 2019	SELL	$250.96 - $284.94 $250 - $284	-1 Reduced 12.5%	7 $2,000
Q1 2019 May 09, 2019	SELL	$276.39 - $362.25 $2,763 - $3,622	-10 Reduced 55.56%	8 $2,000
Q4 2018 Feb 11, 2019	BUY	$281.08 - $444.25 $5,059 - $7,996	18 New	18 $6,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.